quinidine has been researched along with caffeine in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (35.29) | 18.7374 |
1990's | 5 (7.35) | 18.2507 |
2000's | 20 (29.41) | 29.6817 |
2010's | 19 (27.94) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Faassen, F; Spanings, H; Vogel, G; Vromans, H | 1 |
Jolivette, LJ; Ward, KW | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Doh-Ura, K; Go, ML; Nguyen, T; Sakasegawa, Y | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Handzlik, J; Jastrzębska-Więsek, M; Kieć-Kononowicz, K; Kucwaj-Brysz, K; Latacz, G; Lubelska, A; Partyka, A; Wesołowska, A | 1 |
Bojarski, AJ; Cieślik, P; Handzlik, J; Hogendorf, A; Hogendorf, AS; Kieć-Kononowicz, K; Latacz, G; Lubelska, A; Wierońska, JM; Woźniak, M | 1 |
Bartel, K; Bracher, F; Christianson, DW; Herp, D; Jung, M; Marek, M; Müller, M; Ong, N; Porter, NJ; Robaa, D; Romier, C; Schmidtkunz, K; Senger, J; Shaik, TB; Sippl, W; Vögerl, K | 1 |
Atwater, I; Beigelman, PM | 1 |
Huddart, H; Lynch, M | 1 |
Lennard, MS; Loft, S; Otton, SV; Poulsen, HE; Tucker, GT | 1 |
Rafuse, PE; Smith, PA; Zidichouski, JA | 1 |
Guo, JY; He, MS; Zhan, LF; Zhang, YZ | 1 |
Foulks, JG; Perry, FA; Sanders, HD | 1 |
Foulks, JG; Miller, JA; Perry, FA | 2 |
Andersson, KE | 1 |
Batra, S | 1 |
Thorpe, WR | 1 |
Mason, RG; Read, MS; Saba, SR; Shermer, RW | 1 |
Praël, E; Strubelt, O | 1 |
Bondani, A; Karler, R | 1 |
Fairhurst, AS; Hasselbach, W | 1 |
Ingenito, A; Katz, NL; Procita, L | 1 |
Hartung, K; Hermann, A | 1 |
Coleman, RA | 1 |
Kulkarni, SK; Mehta, AK | 1 |
Libao, RG; Su, JY | 1 |
Busselen, P | 1 |
Hasegawa, J; Hirai, S; Kotake, H; Mashiba, H; Narasaki, K; Nawada, T; Tsuboi, M | 1 |
Begnini, J; Bellot, RG; De-La-Vega, DD; Frussa-Filho, R; Jimenez-Bernal, RE; Lopes, FP; Mello, CF; Schwartz, CC | 1 |
Huddart, H; King, JA; Staff, WG | 1 |
Adedoyin, A; Branch, RA; Frye, RF; Romkes, M; Wilson, JW | 1 |
RUMMEL, W; SCHULZ, R | 1 |
MALONE, MH; RAGOZZINO, PW | 1 |
DIMASCOLO, R; MASINI, V | 1 |
CARLASSARE, M | 1 |
Fuhr, U; Kober, S; Mutschler, E; Spahn-Langguth, H; Zaigler, M | 1 |
Banić, B; Jakovljević, V; Vasović, V | 1 |
Capasso, A; Gallo, C | 1 |
Guerin, PM; Kessler, S; Vlimant, M | 1 |
Browne, T; Conti, T; Fiorentin, TR; Krotulski, AJ; Logan, BK; Martin, DM; Triplett, J | 1 |
3 review(s) available for quinidine and caffeine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Ca2+ activated K+ conductance in molluscan neurones.
Topics: Action Potentials; Animals; Apamin; Aplysia; Binding Sites; Caffeine; Calcium; Electric Conductivity; Gallamine Triethiodide; Helix, Snails; Ion Channels; Membrane Potentials; Mollusca; Neurons; Photoreceptor Cells; Potassium; Quinidine; Quinine; Ruthenium Red; Tetraethylammonium Compounds | 1983 |
[THERAPY OF THE MORGAGNI-ADAMS-STOKES SYNDROME].
Topics: Adams-Stokes Syndrome; Adrenal Cortex Hormones; Amphetamine; Amphetamines; Amyl Nitrite; Atropine; Barium; Caffeine; Chlorothiazide; Digitalis Glycosides; Electrocardiography; Ephedrine; Epinephrine; Geriatrics; Heart Block; Heart Massage; Humans; Isoproterenol; Lactates; Magnesium Sulfate; Methamphetamine; Procainamide; Purines; Quinidine; Thyroxine | 1964 |
65 other study(ies) available for quinidine and caffeine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caco-2 Cells; Cell Membrane Permeability; Heterocyclic Compounds; Humans; Protein Transport | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport; Blood-Brain Barrier; Cell Line, Tumor; Dogs; Humans; Madin Darby Canine Kidney Cells; Mice; Peptide Fragments; Permeability; Piperazines; Piperidines; Prion Diseases; Prions; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Quinacrine; Recombinant Proteins; Structure-Activity Relationship | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
Topics: Dose-Response Relationship, Drug; Humans; Hydantoins; Molecular Structure; Piperazines; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 2018 |
Search for a 5-CT alternative.
Topics: | 2018 |
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
Topics: Acetylation; Animals; Catalytic Domain; Cells, Cultured; Crystallography, X-Ray; Histone Deacetylase 6; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Hydroxamic Acids; In Vitro Techniques; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Phenothiazines; Structure-Activity Relationship; Zebrafish | 2019 |
Dynamic characteristics of electrical activity in pancreatic beta-cells. I. - Effects of calcium and magnesium removal.
Topics: Animals; Caffeine; Calcium; Cell Membrane Permeability; Electrophysiology; Exocytosis; Glucose; Islets of Langerhans; Magnesium; Membrane Potentials; Mice; Quinidine | 1976 |
Purinergic modulation of field stimulation responses of rat and human vas deferens smooth muscle.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Electric Stimulation; Guanethidine; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Quinidine; Rats; Receptors, Purinergic; Theophylline; Urinary Bladder; Vas Deferens; Vasodilator Agents | 1991 |
Characterization of metronidazole metabolism by human liver microsomes.
Topics: Acetone; Adult; Benzoflavones; Caffeine; Cytochrome P-450 Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Kinetics; Male; Mephenytoin; Metronidazole; Microsomes, Liver; Middle Aged; Nifedipine; Phenacetin; Quinidine; Theophylline; Tolbutamide | 1991 |
Examination of the role of calcium in the adrenaline-induced hyperpolarization of bullfrog sympathetic neurons.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Apamin; Bufonidae; Caffeine; Calcium; Dantrolene; Electrophysiology; Epinephrine; Gallic Acid; Neurons; Potassium; Quinidine; Sympathetic Nervous System; Tetraethylammonium Compounds; Tubocurarine | 1988 |
[Estimation of residual rate and apparent half-life time of drugs using the method of acute mortality of animals].
Topics: Animals; Caffeine; Half-Life; Kinetics; Lethal Dose 50; Mice; Pest Control, Biological; Quinidine; Spores; Sulfadiazine | 1985 |
Augmentation of caffeine-contracture tension by twitch-potentiating agents in frog toe muscle.
Topics: Androstanes; Animals; Anura; Caffeine; Calcium; Cell Membrane; Chloroform; Drug Interactions; Drug Synergism; Ethers; In Vitro Techniques; Magnesium; Membrane Potentials; Muscle Contraction; Neuromuscular Depolarizing Agents; Nitrates; Pentobarbital; Perchlorates; Potassium; Quinidine; Tetraethylammonium Compounds; Toes; Zinc | 1971 |
Repolarization-induced reactivation of contracture tension in frog skeletal muscle.
Topics: Acetates; Animals; Anura; Caffeine; Calcium; Chlorides; Chloroform; Choline; Ethyl Ethers; Ferrocyanides; In Vitro Techniques; Kinetics; Membrane Potentials; Microelectrodes; Muscle Contraction; Muscles; Perchlorates; Potassium; Quinidine; Time Factors | 1973 |
Effects of chlorpromazine, imipramine, and quinidine on the mechanical activity of single skeletal muscle fibres of the frog.
Topics: Animals; Anura; Caffeine; Chlorpromazine; Drug Synergism; Electric Stimulation; Imipramine; Methods; Muscle Contraction; Myofibrils; Potassium; Quinidine; Rana temporaria; Tendons | 1972 |
The effects of drugs on calcium uptake and calcium release by mitochondria and sarcoplasmic reticulum of frog skeletal muscle.
Topics: Animals; Anura; Biological Transport; Brain; Caffeine; Calcium; Chlorpromazine; Imidazoles; In Vitro Techniques; Mitochondria; Mitochondria, Liver; Mitochondria, Muscle; Muscles; Myocardium; Quinidine; Rana temporaria; Sarcoplasmic Reticulum; Time Factors | 1974 |
Some effects of caffeine and quinidine on sarcoplasmic reticulum of skeletal and cardiac muscle.
Topics: Anesthetics, Local; Animals; Caffeine; Calcium; Heart; In Vitro Techniques; Male; Muscles; Myocardium; Quinidine; Rabbits; Sarcoplasmic Reticulum | 1973 |
Restoration of the ability of frog skeletal muscle to develop potassium contractures in calcium-deficient media.
Topics: Acetates; Androstanes; Animals; Anura; Caffeine; Calcium; Chelating Agents; Chlorides; Ethyl Ethers; Ferrocyanides; Glycols; In Vitro Techniques; Kinetics; Magnesium; Muscle Contraction; Muscles; Nitrates; Pentobarbital; Potassium; Quinidine; Tetraethylammonium Compounds; Time Factors; Zinc | 1973 |
Apparent similarity of mechanisms of platelet adhesion and aggregation. Differentiation of these functions from clot retraction.
Topics: Amitriptyline; Aspirin; Blood Coagulation Tests; Caffeine; Chloromercuribenzoates; Chlorpromazine; Clot Retraction; Cocaine; Diphenhydramine; Ethacrynic Acid; Guanidines; Humans; Phenothiazines; Phentolamine; Phenylbutazone; Platelet Adhesiveness; Promethazine; Quinacrine; Quinidine; Reserpine; Sulfinpyrazone; Sulfones; Tosyl Compounds | 1972 |
[Pharmacological effects on the contraction frequency of isolated rat portal vein].
Topics: Aconitum; Animals; Atropine; Caffeine; Carbachol; Epinephrine; Histamine; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Nitrites; Norepinephrine; Papaverine; Peptides; Phentolamine; Portal Vein; Propranolol; Quinidine; Rats; Rats, Inbred Strains; Reserpine; Strophanthins; Theophylline; Tyramine | 1972 |
Interaction of calcium and local anesthetics with skeletal muscle microsomes.
Topics: Anesthetics, Local; Animals; Benzocaine; Binding Sites; Caffeine; Calcium; Calcium Isotopes; Cell Membrane; Cell-Free System; Cytoplasmic Granules; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Muscle Contraction; Muscles; Ouabain; Procaine; Quinidine; Rats; Sodium; Tetracaine | 1970 |
Calcium efflux from a heavy sarcotubular fraction. Effects of ryanodine, caffeine and magnesium.
Topics: Alkaloids; Animals; Biological Transport; Caffeine; Calcium; Chlorpromazine; Magnesium; Metabolism; Muscles; Oxalates; Quinidine; Rabbits; Uranium; Zinc | 1970 |
Ryanodine-induced contractile failure of skeletal muscle.
Topics: Animals; Caffeine; Cats; Drug Synergism; Electric Stimulation; Epinephrine; Female; Male; Muscle Contraction; Muscles; Quinidine | 1970 |
Purine antagonists in the identification of adenosine-receptors in guinea-pig trachea and the role of purines in non-adrenergic inhibitory neurotransmission.
Topics: Adenosine; Animals; Caffeine; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Phenoxybenzamine; Phentolamine; Purines; Quinidine; Receptors, Drug; Synaptic Transmission; Trachea; Xanthines | 1980 |
Evidence for the presence of P1- and P2-purinoceptors in rat caecum.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Animals; Caffeine; Cecum; Cyclic AMP; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Quinidine; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Theophylline | 1983 |
Intracellular mechanism of quinidine action on muscle contraction. A comparison between rabbit cardiac and skeletal muscle.
Topics: Animals; Caffeine; Calcium; In Vitro Techniques; Magnesium; Muscle Contraction; Muscle Proteins; Muscles; Myocardial Contraction; Quinidine; Rabbits | 1984 |
Effects of caffeine and other substances on sodium- and calcium-independent efflux in cyanide poisoned goldfish ventricles.
Topics: Animals; Biological Transport, Active; Caffeine; Calcium; Cyanides; Goldfish; In Vitro Techniques; Myocardium; Naphazoline; Quinidine; Sarcoplasmic Reticulum; Theophylline | 1980 |
Quinidine enhances intracellular Ca2+ accumulation during rapid stimulation.
Topics: Animals; Caffeine; Calcium; Electric Stimulation; Fura-2; Guinea Pigs; Heart; In Vitro Techniques; Myocardium; Quinidine; Systole | 1995 |
Antinociceptive effect of purine nucleotides.
Topics: Analgesics; Animals; Caffeine; Male; Mice; Naloxone; Narcotic Antagonists; Nociceptors; Purine Nucleotides; Quinidine; Receptors, Purinergic P1; Receptors, Purinergic P2; Rosaniline Dyes; Suramin; Theophylline | 1996 |
Purinergic modulation of rat urinary bladder detrusor smooth muscle.
Topics: Adenosine; Adenosine Triphosphate; Animals; Atropine; Caffeine; Electric Stimulation; In Vitro Techniques; Labetalol; Male; Muscle, Smooth; Purinergic Agonists; Purinergic Antagonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Quinidine; Rats; Rats, Wistar; Receptors, Purinergic; Urinary Bladder | 1997 |
In vivo modulation of CYP enzymes by quinidine and rifampin.
Topics: Acetylation; Administration, Oral; Adrenergic alpha-Antagonists; Adult; Anti-Arrhythmia Agents; Antibiotics, Antitubercular; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dapsone; Debrisoquin; Drug Administration Schedule; Enzyme Inhibitors; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Quinidine; Reference Values; Rifampin; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Theophylline | 2000 |
[Comparison of blocking and deblocking substances in diaphragm-phrenicus preparation in rat. II].
Topics: Abdominal Muscles; Animals; Caffeine; Calcium; Calcium, Dietary; Diaphragm; Muscle Relaxants, Central; Neuromuscular Junction; Parasympathomimetics; Quinidine; Rats | 1954 |
BIODYNAMICS OF THIOUREA-ALKALOID COMBINATIONS.
Topics: Absorption; Alkaloids; Anti-Bacterial Agents; Blood Chemical Analysis; Caffeine; Intestines; Metabolism; Penicillins; Pharmacology; Quinidine; Quinine; Rats; Research; Salicylic Acid; Thiourea | 1963 |
[ANALYSIS OF GALENIC PREPARATIONS. QUINA-KOLA SYRUP].
Topics: Caffeine; Chemistry, Pharmaceutical; Cinchona; Pharmacy; Quinidine; Quinine; Research | 1964 |
Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
Topics: Caffeine; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythromycin; Humans; Hydroxylation; Ketoconazole; Kinetics; Microsomes, Liver; Omeprazole; Quinidine; Substrate Specificity; Sulfuric Acid Esters; Theophylline; Triamterene | 2005 |
Effect of caffeine on quinidine transport to the central nervous system in rats.
Topics: Animals; Biological Transport, Active; Blood-Brain Barrier; Brain; Caffeine; Central Nervous System Stimulants; Drug Synergism; Female; Injections, Intra-Arterial; Male; Quinidine; Rats; Rats, Wistar | 2007 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |
The sugar meal of the African malaria mosquito Anopheles gambiae and how deterrent compounds interfere with it: a behavioural and neurophysiological study.
Topics: Action Potentials; Analysis of Variance; Animals; Anopheles; Berberine; Caffeine; Chemoreceptor Cells; Feeding Behavior; Female; Fructose; Glucose; Microscopy, Electron, Transmission; Nigeria; Quaternary Ammonium Compounds; Quinidine; Quinine; Sensilla; Sucrose | 2013 |
Detection of Cutting Agents in Drug-Positive Seized Exhibits within the United States.
Topics: Acetaminophen; Caffeine; Chromatography, Liquid; Drug Contamination; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Kentucky; Levamisole; Procaine; Quinidine; Quinine; Vermont | 2019 |